page_banner

product

Doxofylline(CAS# 69975-86-6)

Chemical Property:

Molecular Formula C11H14N4O4
Molar Mass 266.25
Density 1.2896 (rough estimate)
Melting Point 144-146°C
Boling Point 409.46°C (rough estimate)
Flash Point 259.3°C
Water Solubility Soluble
Solubility Soluble in water, acetone, ethyl acetate, benzene, chloroform, dioxane, hot methanol or hot ethanol, almost insoluble in ether or petroleum ether.
Vapor Presure 2.49E-10mmHg at 25°C
Appearance Crystallization
Color White to Off-White
Merck 14,3438
pKa 0.42±0.70(Predicted)
Storage Condition under inert gas (nitrogen or Argon) at 2-8°C
Refractive Index 1.6000 (estimate)
MDL MFCD00865218

Product Detail

Product Tags

Risk and Safety

Hazard Symbols Xi – Irritant
Risk Codes 36/37/38 – Irritating to eyes, respiratory system and skin.
Safety Description S26 – In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37 – Wear suitable protective clothing and gloves.
RTECS XH5135000
HS Code 29399990
Toxicity LD50 in mice (mg/kg): 841 orally; 215.6 i.v.; in rats: 1022.4 orally, 445 i.p. (Franzone)

 

Doxofylline(CAS# 69975-86-6) Introducing

Introducing Doxofylline (CAS# 69975-86-6) – a revolutionary bronchodilator designed to enhance respiratory health and improve the quality of life for individuals suffering from chronic respiratory conditions. As a member of the xanthine class of medications, Doxofylline offers a unique mechanism of action that sets it apart from traditional bronchodilators, making it an essential addition to the therapeutic arsenal for asthma and chronic obstructive pulmonary disease (COPD) management.

Doxofylline works by relaxing the smooth muscles of the airways, leading to improved airflow and reduced respiratory distress. Its dual action not only dilates the bronchial passages but also possesses anti-inflammatory properties, addressing the underlying inflammation that often exacerbates respiratory conditions. This makes Doxofylline an effective choice for patients seeking relief from wheezing, shortness of breath, and other symptoms associated with asthma and COPD.

One of the standout features of Doxofylline is its favorable safety profile. Unlike some other bronchodilators, it is less likely to cause side effects such as tachycardia or gastrointestinal disturbances, making it suitable for long-term use. Additionally, Doxofylline is available in various formulations, including tablets and inhalers, providing flexibility and convenience for patients in managing their condition.

With its proven efficacy and safety, Doxofylline is quickly becoming a preferred choice among healthcare professionals. It empowers patients to take control of their respiratory health, allowing them to engage in daily activities with confidence and ease.

Experience the difference with Doxofylline – a trusted ally in the fight against respiratory ailments. Consult your healthcare provider today to learn more about how Doxofylline can help you breathe easier and live better.


  • Previous:
  • Next:

  • Write your message here and send it to us